IPP Bureau
BD, Suttons Creek partner to streamline combination product development
By IPP Bureau - April 30, 2026
The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration
RPG Life Sciences reports Rs 707.5 crore revenue in FY26, 8% annual growth
By IPP Bureau - April 30, 2026
In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth
Syngene reports FY26 revenue of Rs 3,739 Cr, up 3%; Q4 revenue at Rs 1,037 Cr
By IPP Bureau - April 30, 2026
Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities
Sahajanand Medical Technologies secures ISO 50001:2018 certification for Surat, Hyderabad facilities
By IPP Bureau - April 30, 2026
Certification reinforces energy efficiency, sustainability goals, and green manufacturing across SMT’s Surat and Hyderabad facilities
Solara announces closure of US FDA inspection at Puducherry facility
By IPP Bureau - April 30, 2026
The Puducherry facility, dedicated to Ibuprofen and its derivatives, is equipped with advanced infrastructure to serve both domestic and international markets
Wanbury's Patalganga site clears Korea FDA inspection with zero observations
By IPP Bureau - April 30, 2026
Patalganga plant received zero observation from USFDA earlier
KIMS enters into MoU for strategic clinical collaboration
By IPP Bureau - April 30, 2026
The association is intended to strengthen healthcare delivery standards, particularly in Oncology services, and enhance patient care outcomes
Pfizer drug delivers breakthrough in late-stage blood cancer trial
By IPP Bureau - April 30, 2026
Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis
Teva strikes $900M bet on breakthrough Tourette drug with Emalex buyout
By IPP Bureau - April 30, 2026
The agreement could rise to $900 million if key commercial milestones are met
Zealand Pharma and Roche charge into Phase 3 with obesity drug bet
By IPP Bureau - April 30, 2026
The Danish biotech company confirmed the global study will begin in the second half of 2026
Gen Z split on AI as global study reveals rising tech optimism
By IPP Bureau - April 30, 2026
Health innovations are viewed more positively than food and agricultural technologies
Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy
By IPP Bureau - April 29, 2026
Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
Leinco Technologies and CellCarta partner to advance proteomics in immuno-oncology
By IPP Bureau - April 29, 2026
The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use
Sanofi Consumer Healthcare reports 33% revenue growth in Q1 FY26; PAT rises 36%
By IPP Bureau - April 29, 2026
Domestic sales increased 15.5%, supported by the relaunch of previously recalled products in the market
Gleneagles BGS Hospital launches HEAL Health Card to expand access to affordable care
By IPP Bureau - April 29, 2026
The initiative is designed to benefit patients as well as healthcare providers by streamlining access to consultations, diagnostics, and essential care services
